Image Source: ET Pharma
Indegene Limited has announced the merger of its step-down subsidiaries, Indegene Aptilon Services, Inc. and Trilogy Writing & Consulting Inc., to form a new entity—Indegene Healthcare Canada Inc. The internal restructuring aims to enhance operational efficiency and alignment across its North American operations, effective January 1, 2026.
Show more
Indegene Limited informed that its wholly owned US subsidiary, Indegene, Inc., has completed the amalgamation of two of its 100% held step-down subsidiaries—Indegene Aptilon Services, Inc. and Trilogy Writing & Consulting Inc. (formerly Trilogy Writing and Consulting ULC, Canada). The merger, effective January 1, 2026, results in the formation of Indegene Healthcare Canada Inc.
Key Details And Highlights:
-
The amalgamation combines Indegene Aptilon Services, Inc. and Trilogy Writing & Consulting Inc., bringing together their specialized expertise.
-
The projected revenue for FY25-26 stands at CAD 1.37 million for Aptilon Services and CAD 5.4 million for Trilogy Writing.
-
Both entities operate within the life sciences and healthcare space, with Trilogy focusing on medical writing and regulatory documentation, and Indegene offering digital-first commercialization solutions for biopharmaceutical and medical-device companies.
-
The merger is categorized as a related party transaction conducted at arm’s length.
-
It is an internal restructuring exercise; no cash consideration or change in shareholding of the listed entity is involved.
Source: Corporate filing with BSE and NSE
Stay Ahead – Explore Now!
ICICI Bank Receives ₹160.3M GST Demand, Reviews Compliance Options
Advertisement
Advertisement